Deregulation of RHOT1 expression may be a risk factor for pancreatic cancer in NF1 microdeletion patients, although the reported data refer to NF1 patients without distinguishing between different forms of NF1. The gene discussed is NF1; the disease is familial pancreatic carcinoma.